tiprankstipranks
Alterola Biotech (ABTI)
OTHER OTC:ABTI
US Market

Alterola Biotech (ABTI) Stock Price & Analysis

10 Followers

ABTI Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.05
Previous Close$0.01
Volume2.00K
Average Volume (3M)N/A
Market Cap
$6.84M
Enterprise Value$7.09M
Total Cash (Recent Filing)$2.57K
Total Debt (Recent Filing)$244.06K
Price to Earnings (P/E)-5.0
Beta0.88
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,382,662,952
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation2.45
R-Squared0.00535
Alpha0.33
Financial Highlights & Ratios
Price to Book (P/B)-3.27
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-46.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

ABTI FAQ

What was Alterola Biotech’s price range in the past 12 months?
Alterola Biotech lowest stock price was <$0.01 and its highest was $0.05 in the past 12 months.
    What is Alterola Biotech’s market cap?
    Currently, no data Available
    When is Alterola Biotech’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Alterola Biotech’s earnings last quarter?
    Currently, no data Available
    Is Alterola Biotech overvalued?
    According to Wall Street analysts Alterola Biotech’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Alterola Biotech pay dividends?
      Alterola Biotech does not currently pay dividends.
      What is Alterola Biotech’s EPS estimate?
      Alterola Biotech’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Alterola Biotech have?
      Alterola Biotech has 1,382,663,000 shares outstanding.
        What happened to Alterola Biotech’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Alterola Biotech?
        Currently, no hedge funds are holding shares in ABTI
        ---

        Alterola Biotech Stock Smart Score

        N/A
        Not Ranked
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Fundamentals

        Return on Equity
        -64.68%
        Trailing 12-Months
        Asset Growth
        -99.97%
        Trailing 12-Months

        Company Description

        Alterola Biotech

        Alterola Biotech, Inc. is a development stage company. It engages in the development of chewing gums for the delivery of nutraceutical and functional ingredients for applications such as appetite suppressant, cholesterol suppressant, vitamin delivery, antioxidant delivery, and motion sickness suppressant. The company was founded on July 21, 2008 and is headquartered in Walnut, CA.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Arca Biopharma
        Abeona Therapeutics
        Arbutus Biopharma
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis